CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2022	Mar. 31, 2021
TOTAL REVENUE		$ 16,085	$ 11,320
COST OF GOODS SOLD	[1]	(6,034)	(4,765)
RESEARCH AND DEVELOPMENT EXPENSES	[2]	(8,767)	(7,122)
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES	[3]	(3,154)	(3,138)
OPERATING LOSS		(1,870)	(3,705)
FINANCIAL EXPENSES		(618)	(2,156)
FINANCIAL INCOME		202	335
FINANCIAL EXPENSES - NET		(416)	(1,821)
OTHER INCOME			51
NET LOSS FOR THE PERIOD		$ (2,286)	$ (5,475)
LOSS PER SHARE OF COMMON STOCK - BASIC		$ (0.05)	$ (0.14)
LOSS PER SHARE OF COMMON STOCK - DILUTED		$ (0.05)	$ (0.14)
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING LOSS PER SHARE - BASIC		45,843,563	39,933,972
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING LOSS PER SHARE - DILUTED		45,843,563	39,933,972
Goods [Member]
TOTAL REVENUE		$ 9,028	$ 4,511
License and R&D Services [Member]
TOTAL REVENUE		$ 7,057	$ 6,809

[1] (1) Includes share-based compensation

[2] (2) Includes share-based compensation

[3] (3) Includes share-based compensation